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This study aimed to examine the eﬀect of AC iontophoresis on rats with the chronic constriction injury (CCI) to the infraorbital
nerve by animal experiments. CCI model rats were divided into four groups, namely, rats that received general anesthesia for
60min except AC IOP (CCI: n = 5), AC IOP with 0.9% physiological saline for 60min (CCI + saline AC IOP: n = 5), AC IOP
with 4% lidocaine hydrochloride for 60min (CCI + lidocaine AC IOP: n = 5), and attachment of two electrodes soaked with 4%
lidocaine hydrochloride to the facial skin for 60min (CCI + attach lidocaine: n = 5). In the CCI + lidocaine AC IOP group, an
elevated withdrawal threshold was observed after AC IOP, and the duration of eﬃcacy was longer compared with that in the CCI
+ saline AC IOP and CCI + attached lidocaine groups. A signiﬁcant decrease in the number of Fos-like immunoreactive (LI) cells
was observed in the CCI + lidocaine AC IOP group compared with that in the CCI group. These ﬁndings suggest that the eﬀect of
CCI + lidocaine AC IOP group may be caused by active permeation of lidocaine into the facial skin and electrical stimulation of
the trigeminal nucleus.
1.Introduction
It is diﬃcult to control pain caused by nerve injury with
medications such as anti-inﬂammatory agents and antibi-
otics. Medications recommended for neuropathic pain
are antidepressants, calcium channel a2-d ligands, opioid
agonists, tramadol, and so on [1]. In our clinic, many
medicines such as antidepressants, anticonvulsants, and
antianxiety medications are usually used together with
cognitive-behavioraltreatmenttotreatthesepatients.Kampo
(Japanesetraditionalmedicine)andacupuncturetherapyare
also used. In addition, we provide photodynamic therapy
and alternating current (AC) iontophoresis (Figure 1).
Transdermal drug delivery can be enhanced by chemical
and physical enhancement systems. Iontophoresis is one of
the physical enhancement systems using electrical energy [2,
3]. Two electrodes are placed apart from each other on the
skin, and charged drugs are transported through the skin by
electrophoresis. Electroosmosis generated within the skin by
electric current also enables transport of hydrated water ions
inside the skin [4, 5].
The principle of iontophoresis was ﬁrst described by
Veratti in 1747, and in the last century, experiments were
performed using a range of diﬀerent pharmaceutical agents.
In 1975, Echols et al. investigated the eﬀect of iontophoresis
on the mucosa of the inner ears of guinea pigs using 4%
lidocaine hydrochloride [6], and researches in the ﬁelds
of otolaryngology and dentistry mainly focused on its
application as a method of local anesthesia.
Direct current (DC) is normally used in iontophoresis;
however, it often causes skin irritations, burns, and inﬂam-
mation [7]. In addition to its side eﬀects, the fact that
electrode polarization often occurs during DC iontophoresis
suggests that the method cannot be applied for longer
durations [8, 9]. To overcome these side eﬀects, Reinauer




Figure 1: The electrodes were made of cotton and aluminum
foil (a). A pulsed alternating current (AC) voltage generator was
used (LASPER; Sankyo Electric Co., Japan) (b). A photograph of
application to a patient (c).
AC iontophoresis causes little skin irritation and does not
result in electrode polarization; therefore, it can be used for
longer duration than DC iontophoresis. Taking advantage
of these characteristics, we clinically apply AC iontophoresis
with 4% lidocaine hydrochloride in our department to treat
neuropathic pain.
With respect to the mechanism of enhancing percu-
taneous absorption by AC iontophoresis, Shibaji et al.
hypothesized in 2001 that the decrease of eﬀective Stokes
radius of the ion with an increase in the vibration energy
of the ion caused by alternating electric potential applied
between electrodes plays a decisive role in ion transportation
[11].
Although AC iontophoresis has been conﬁrmed to be
clinically eﬀective, the mechanism of action is still unclear.
In the present study, the eﬀect of AC iontophoresis was
examined in rat experiments.
2.MaterialsandMethods
Animal experiments were conducted using chronic constric-
tion injury (CCI) as a model of neuropathic pain to evaluate
the eﬀect of AC iontophoresis.
2.1. Animals. Forty-ﬁve male Sprague-Dawley rats
(240˜ g300g) were used. The rats were housed under a
12-hour light/dark cycle with food and water available ad
libitum. The rats were treated according to the guidelines
of the International Association for the Study of Pain [12].
This study was approved by the Institutional Animal Care
and Use Committee of Tokyo Medical and Dental University
(no. 0080093).
2.2. Chronic Constriction Injury (CCI) Model Rats. With-
drawal threshold was measured by using von Frey monoﬁl-
aments before the operation. CCI was performed using
the method of Imamura et al. [13] .T h er a t sw e r ea n e s -
thetized with pentobarbital sodium [50mg/kg intraperi-
toneally (i.p.)]; an incision was made intraorally, and the
left infraorbital nerve was exposed. Two loosely constrictive
ligatures were tied around the nerve with 4.0 chromic gut
sutures. Following this, the incision was sutured using 4.0
silk.
The withdrawal threshold was again measured 7 days
after the operation and compared with data before the oper-
ation. The that rats showed signiﬁcant decrease withdrawal
threshold were recognized as the CCI model rats.
The sham operation was the same as the CCI operation
except for the nerve ligature (n = 5).
2.3. AC Iontophoresis (AC IOP). The electrical stimulator
used for AC IOP was a clinical device (LASPER CS-504;
Sankyo Electric Co., Japan). The electrode was made of
cotton and a copper wire mesh. One electrode was soaked by
0.05mLof4%lidocainehydrochlorideor0.9%physiological
saline. Two electrodes were placed on the facial skin of the
maxillary nerve area and ﬁxed with surgical tape, and a
pulsed AC voltage (1V, 50Hz) was applied for 60min.
2.4. Behavioral Experiment. The CCI model rats were
divided into four groups, namely, rats that received anes-
thesia for 60min except AC IOP (CCI group, n = 5), AC
IOP with 0.9% physiological saline applied to the rats for
60min (CCI + saline AC IOP group, n = 5), AC IOP with
4% lidocaine hydrochloride applied to the rats for 60min
(CCI + lidocaine AC IOP group, n = 5), and placement of
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Figure 2: Change in mechanical withdrawal thresholds 7 days
after chronic constriction injury (CCI) (mean ± SEM). The values
of 7 days after CCI decreased signiﬁcantly on the ipsilateral side
compared with the preoperative values. In addition, a signiﬁcant
diﬀerence was observed between the sham group and other groups.
∗P<0.05,n = 5.
the facial skin for 60min (CCI + attach lidocaine group:
n = 5).
The mechanical withdrawal threshold was measured
prior to anesthesia using von Frey monoﬁlaments. Mechani-
calstimulationwasappliedtothewhiskerpadandalternately
applied to the contralateral (right) and ipsilateral (left) sides.
The mechanical withdrawal threshold was determined as the
lowest force that caused a head withdrawal response. Each
monoﬁlament was applied three times at intervals of 5sec.
If a rat showed a head withdrawal response or grooming
of the whisker pads, even one of the three times, the
corresponding force was considered to cause a withdrawal
response. Mechanical withdrawal thresholds were measured
ﬁve times, and the median of the ﬁve values was determined
to be the mechanical withdrawal threshold of the rat. These
values were then averaged for each group. The mechanical
withdrawal threshold in the CCI group was compared with
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Figure 3: After 60min treatment, mechanical withdrawal thresh-
olds were measured at 0, 30, 60, 90, and 120min. A signiﬁcant
increase in the withdrawal threshold was observed in the CCI +
lidocaine AC IOP group until 60min after treatment. The value in
the CCI + saline AC IOP group at 0min also increased signiﬁcantly.
The values in the CCI + attach lidocaine group at 0min increased
signiﬁcantly compared with those prior to AC IOP; however no
signiﬁcant diﬀerence was observed compared with the values in the
CCI group. All the changes were observed on the ipsilateral side.
∗,#P<0.05, n = 5.
that in the sham group to demonstrate that the change in
the withdrawal threshold was not caused by inﬂammation
because of the operation.
The rats were anesthetized with pentobarbital sodium
(50mg/kg i.p.), and two electrodes were placed on the facial
skin of the maxillary nerve area and ﬁxed with surgical tape.
General anesthesia was maintained with 1% ∼4% halothane.
Each group was treated for 60min. The mechanical with-
drawal threshold was measured at 0, 30, 60, 90, and 120min
after treatment.
2.5. Immunohistological Experiment. Twenty CCI model rats
were divided into four groups as seen for the behavioral
experiments. After treatment, the mechanical stimulation4 International Journal of Dentistry
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(60g, 0.5Hz, 10min) was applied to the rats with a
von Frey monoﬁlament. Two hours later, the rats were
anesthetized with pentobarbital sodium (80mg/kg i.p.) and
perfused through the aorta with 0.9% physiological saline
300mLand4%paraformaldehydein 0.1Mphosphatebuﬀer
(PB) 300mL. The brain and medulla were removed, and
immersed in 4% paraformaldehyde in 0.1M PB for 3 days
at 4◦C, and transferred to 30% sucrose (w/v) in 0.1M PB for
several days for cryoprotection.
The sections were cut on a freezing microtome in
thickness of 30µm, and every fourth section was collected in
0.02M phosphate buﬀer saline (PBS). Free-ﬂoating sections
were washed in PBS and then treated with 3% hydrogen
peroxide (H2O2) in PBS for 10min. After three washes
with PBS, the sections were incubated with 3% normal
goat serum (NGS) for 2 hours. Following this, the sections
were incubated with rabbit anti-Fos (1:10,000; c-fos ab-5,
Oncogene, Cambridge, MA, USA) in 3% NGS overnight
at 25◦C. After three washes with PBS, the sections were
incubated with biotinylated secondary IgG (1:200; Vector
Labs, Burlingame, CA, USA) for 2 hours at 25◦C. After
three washes with PBS, the sections were incubated with
peroxidase-conjugated avidin-biotin complex (1:100; ABC,
Vector Labs) for 2 hours at 25◦C. Following three rinses
with PBS and one rinse with 0.05M Tris-buﬀer (TB), the
sections were immersed in 0.035% 3,3 -diaminobenzidine-
tetra HCl (DAB, Sigma, St. Louis, MO, USA), 0.2% nickel
ammonium sulfate, and 0.05% peroxide in 0.05M TB.
Finally, the sections were rinsed in PBS, mounted on gelatin-
coated slides dehydrated in alcohol, cleared in xylene, and
covered with Eukitt (O. Kindler, Freiburg, Germany).
The cells with black deposits in the nuclei were consid-
ered to be Fos-like immunoreactive (LI) cells. The number
of Fos-LI cells was counted per section per rat. The mean
number of Fos -LI cells was calculated for ﬁve rats.
2.6. Analyses. Data are presented as means ± standard
error of the mean (SEM). One-way ANOVA was used to
analyze the diﬀerence between the groups in the behavioral
and immunohistological experiments. Post hoc comparisons
wereperformedwithBonferronitesttoassessthemechanical
withdrawal thresholds at 7 days after CCI. And post hoc
comparisons were performed with Dunnett test to assess
the change in the mechanical withdrawal thresholds after
treatments and distribution of expression of Fos-LI cells
in the trigeminal nucleus. P values of less than 0.05 were
considered statistically signiﬁcant.
3. Result
Mechanical withdrawal thresholds in all the groups of rats
that received CCI decreased signiﬁcantly on the ipsilateral
side compared with those in the sham group (Figure 2). In
the CCI + lidocaine AC IOP group, the withdrawal threshold
duringthebehavioralexperimentswaselevatedafterACIOP,
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Figure 5: Distribution of the expression of Fos-LI cells in the trigeminal nucleus. The CCI + lidocaine AC IOP group showed a
decrease in the number of Fos-LI cells from −2.4mm to −0.6mm in the trigeminal nucleus. The number of Fos-LI cells decreases from
−1.8mm to −1.2mm in the trigeminal nucleus of the CCI + saline AC IOP group and the CCI + attach lidocaine group. No signiﬁcant
diﬀerence in the number of Fos-LI cells was observed on the contralateral side. ∗P<0.05, n = 5.
in the CCI + saline AC IOP group and the CCI + attach
lidocaine group (Figure 3).
The immunohistological experiment revealed expression
of Fos-LI cells in the trigeminal spinal nucleus (Figures 4 and
5).IntheCCIgroup,theexpressionofnumerousFos-LIcells
was observed in an area 1.2mm cranial and 3.6mm caudal
from the obex. In the CCI + lidocaine AC IOP group, a
signiﬁcant decrease was observed in the expression of Fos-LI
cells compared with that in the CCI group in an area 0.6mm
caudal to 2.4mm caudal from the obex. The location of this
zone corresponds to the trigeminal subnucleus caudalis. A
decrease in the number of Fos-LI cells was also observed in
anarea1.2mmcaudalto1.8mmcaudalfromtheobexinthe
CCI + saline AC IOP and CCI + attach lidocaine group.
Thus, the expression of Fos-LI cells was suppressed over
a wide area in the CCI + lidocaine AC IOP group compared
with that in the other two groups.
4. Discussion
Nerve ﬁbers enter inside the teeth through the jawbone, and
many dental procedures can potentially aﬀect these nerve
ﬁbers. Indeed, dental treatment may occasionally result in
neuropathic pain [14, 15].
Neuropathic pain has been treated by various methods.
In our department, we usually employ AC iontophoresis as
one of the methods to manage neuropathic pain [16–19].
Iontophoresis is a method of utilizing electrical energy to
transportdrugsthroughtheskin. DCiontophoresis hasbeen
widely used in various ﬁelds such as ophthalmic surgery,
anesthesia of the tympanic membrane, diagnosis of cystic
ﬁbrosis, and treatment of hyperhidrosis [20–23]. Although
commercial devices are available, DC iontophoresis creates
some problems such as skin burns [7] and electrode
polarization [8, 9].
Therefore, the AC iontophoresis is used to treat orofacial
pain in our clinic to avoid these disadvantages of DC
iontophoresis.
In the present study, an elevated withdrawal threshold
and a reduced number of Fos-LI cells were observed in the
CCI + saline AC IOP group and CCI + lidocaine AC IOP
group. The saline did not have a local anesthesia eﬀect,
indicating that electrical stimulation may have exerted some
eﬀect on the central pain pathway.
The duration of elevation of the withdrawal threshold in
theCCI+lidocaineACIOPgroupwaslongercomparedwith
that in the CCI + saline AC IOP group and CCI + attach
lidocaine group. The eﬀect of 4% lidocaine hydrochloride
AC iontophoresis treatment lasted over several days in our
clinical case [12, 13]. The eﬀect of CCI + saline AC IOP
group may have been caused by electrical stimulation of the
trigeminal nucleus, and the eﬀect of CCI + attach lidocaine
group may have been caused by passive diﬀusion of the
lidocaine into the facial skin. Kinoshita et al. reported that6 International Journal of Dentistry
the transdermal delivery of lidocaine by AC iontophoresis
has a possibility to use for local anesthesia and the pain
management of the skin [24]. Therefore, AC iontophoresis
probably allows lidocaine to pass actively through the skin.
These ﬁndings suggest that the eﬀect of CCI + lidocaine
A CI O Pg r o u pm a yh a v eb e e nc a u s e db ya c t i v ed i ﬀusion of
lidocaine through the facial skin and electrical stimulation of
the trigeminal nucleus.
Thus, this study suggests that AC iontophoresis has a
possibilitytobeausefultreatmentforpatientssuﬀeringfrom
neuropathic pain caused by oral and maxillofacial surgery.
Recently, many studies have been conducted on the AC
iontophoresis. These studies demonstrated that lidocaine
transport depends on voltage, time, and frequency [25, 26].
Studies of electrical waveforms and electrodes have also been
conducted [27, 28]. However, further studies are needed to
p r o v i d es a f ea n de ﬀective AC iontophoresis therapy.
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